|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 400 out of 848 for Htt

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.043s

Categories

Category: Publication
« show all
Type Details Score
Publication
23195593 | J:196980
 
First Author: Dougherty SE
Year: 2013
Journal: Exp Neurol
Title: Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease.
Volume: 240
Pages: 96-102
•
•
•
•
•
Publication
25447230 | J:258597
 
First Author: Träger U
Year: 2015
Journal: Neurobiol Dis
Title: Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.
Volume: 73
Pages: 388-98
•
•
•
•
•
Publication
30193095 | J:266738
First Author: Ast A
Year: 2018
Journal: Mol Cell
Title: mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease.
Volume: 71
Issue: 5
Pages: 675-688.e6
•
•
•
•
•
Publication
19956633 | J:155387
First Author: Moffitt H
Year: 2009
Journal: PLoS One
Title: Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.
Volume: 4
Issue: 11
Pages: e8025
•
•
•
•
•
Publication
19279257 | J:147069
First Author: Heng MY
Year: 2009
Journal: J Neurosci
Title: In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease.
Volume: 29
Issue: 10
Pages: 3200-5
•
•
•
•
•
Publication
16624677 | J:112811
First Author: Brooks SP
Year: 2006
Journal: Brain Res Bull
Title: Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease.
Volume: 69
Issue: 4
Pages: 452-7
•
•
•
•
•
Publication
26908599 | J:229738
First Author: Kumar A
Year: 2016
Journal: Hum Mol Genet
Title: Allelic series of Huntington's disease knock-in mice reveals expression discorrelates.
Volume: 25
Issue: 8
Pages: 1619-36
•
•
•
•
•
Publication
28099507 | J:247976
First Author: Rattray I
Year: 2017
Journal: PLoS One
Title: Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's Disease.
Volume: 12
Issue: 1
Pages: e0168556
•
•
•
•
•
Publication
31499139 | J:282567
 
First Author: Cao JK
Year: 2019
Journal: Neurobiol Dis
Title: Sex-dependent impaired locomotion and motor coordination in the HdhQ200/200 mouse model of Huntington's Disease.
Volume: 132
Pages: 104607
•
•
•
•
•
Publication
22984513 | J:192895
First Author: Marcellin D
Year: 2012
Journal: PLoS One
Title: Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging.
Volume: 7
Issue: 9
Pages: e44457
•
•
•
•
•
Publication
34884469 | J:317742
 
First Author: Back MK
Year: 2021
Journal: Int J Mol Sci
Title: C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice.
Volume: 22
Issue: 23
•
•
•
•
•
Publication
18299573 | J:132766
First Author: Gonitel R
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: DNA instability in postmitotic neurons.
Volume: 105
Issue: 9
Pages: 3467-72
•
•
•
•
•
Publication
30179155 | J:269426
   
First Author: Arnoux I
Year: 2018
Journal: Elife
Title: Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease.
Volume: 7
•
•
•
•
•
Publication
34341363 | J:311426
First Author: Lovergne L
Year: 2021
Journal: Sci Rep
Title: An infrared spectral biomarker accurately predicts neurodegenerative disease class in the absence of overt symptoms.
Volume: 11
Issue: 1
Pages: 15598
•
•
•
•
•
Publication
17352931 | J:128653
First Author: Woodman B
Year: 2007
Journal: Brain Res Bull
Title: The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.
Volume: 72
Issue: 2-3
Pages: 83-97
•
•
•
•
•
Publication
17394466 | J:144268
First Author: Oliveira JM
Year: 2007
Journal: J Neurochem
Title: Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice.
Volume: 101
Issue: 1
Pages: 241-9
•
•
•
•
•
Publication
24086450 | J:206483
First Author: Young D
Year: 2013
Journal: PLoS One
Title: Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice.
Volume: 8
Issue: 9
Pages: e75108
•
•
•
•
•
Publication
16237181 | J:102158
First Author: DĂ­az-HernĂ¡ndez M
Year: 2005
Journal: J Neurosci
Title: Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease.
Volume: 25
Issue: 42
Pages: 9773-81
•
•
•
•
•
Publication
10778856 | J:61490
First Author: Yamamoto A
Year: 2000
Journal: Cell
Title: Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.
Volume: 101
Issue: 1
Pages: 57-66
•
•
•
•
•
Publication
12969257 | J:135605
First Author: Zhang Y
Year: 2003
Journal: J Neurochem
Title: Depletion of wild-type huntingtin in mouse models of neurologic diseases.
Volume: 87
Issue: 1
Pages: 101-6
•
•
•
•
•
Publication
8898202 | J:36689
First Author: Mangiarini L
Year: 1996
Journal: Cell
Title: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
Volume: 87
Issue: 3
Pages: 493-506
•
•
•
•
•
Publication
11752065 | J:73480
First Author: Bogdanov MB
Year: 2001
Journal: J Neurochem
Title: Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease.
Volume: 79
Issue: 6
Pages: 1246-9
•
•
•
•
•
Publication
11152662 | J:67073
First Author: Fain JN
Year: 2001
Journal: Hum Mol Genet
Title: Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation.
Volume: 10
Issue: 2
Pages: 145-52
•
•
•
•
•
Publication
33940179 | J:322257
 
First Author: Lee M
Year: 2021
Journal: Neurobiol Dis
Title: Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease.
Volume: 155
Pages: 105374
•
•
•
•
•
Publication
12913073 | J:85070
First Author: Li H
Year: 2003
Journal: Hum Mol Genet
Title: Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release.
Volume: 12
Issue: 16
Pages: 2021-30
•
•
•
•
•
Publication
11821898 | J:74541
First Author: Karpuj MV
Year: 2002
Journal: Nat Med
Title: Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.
Volume: 8
Issue: 2
Pages: 143-9
•
•
•
•
•
Publication
19124532 | J:145751
First Author: Phan J
Year: 2009
Journal: Hum Mol Genet
Title: Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models.
Volume: 18
Issue: 6
Pages: 1006-16
•
•
•
•
•
Publication
27486903 | J:256913
First Author: McCourt AC
Year: 2016
Journal: PLoS One
Title: White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington's Disease.
Volume: 11
Issue: 8
Pages: e0159870
•
•
•
•
•
Publication
19692612 | J:151920
First Author: Cummings DM
Year: 2009
Journal: J Neurosci
Title: Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Volume: 29
Issue: 33
Pages: 10371-86
•
•
•
•
•
Publication
9267033 | J:42085
First Author: Davies SW
Year: 1997
Journal: Cell
Title: Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
Volume: 90
Issue: 3
Pages: 537-48
•
•
•
•
•
Publication
27916455 | J:253268
First Author: Beaumont V
Year: 2016
Journal: Neuron
Title: Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models.
Volume: 92
Issue: 6
Pages: 1220-1237
•
•
•
•
•
Publication
11032906 | J:65206
First Author: Hickey MA
Year: 2000
Journal: J Neurochem
Title: Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity.
Volume: 75
Issue: 5
Pages: 2163-71
•
•
•
•
•
Publication
10098889 | J:53593
First Author: Reynolds GP
Year: 1999
Journal: J Neurochem
Title: Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation.
Volume: 72
Issue: 4
Pages: 1773-6
•
•
•
•
•
Publication
27646506 | J:261929
 
First Author: Ouk K
Year: 2016
Journal: Exp Neurol
Title: Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
Volume: 286
Pages: 69-82
•
•
•
•
•
Publication
28578004 | J:258971
 
First Author: Sebastianutto I
Year: 2017
Journal: Neurobiol Dis
Title: Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.
Volume: 105
Pages: 117-131
•
•
•
•
•
Publication
30321100 | J:340213
First Author: Chanda K
Year: 2018
Journal: RNA Biol
Title: Altered Levels of Long NcRNAs Meg3 and Neat1 in Cell And Animal Models Of Huntington's Disease.
Volume: 15
Issue: 10
Pages: 1348-1363
•
•
•
•
•
Publication
28031289 | J:241431
 
First Author: Ouk K
Year: 2016
Journal: Hum Mol Genet
Title: Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's disease.
Volume: 25
Issue: 24
•
•
•
•
•
Publication
10434296 | J:56820
First Author: Cha JH
Year: 1999
Journal: Philos Trans R Soc Lond B Biol Sci
Title: Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease.
Volume: 354
Issue: 1386
Pages: 981-9
•
•
•
•
•
Publication
11592850 | J:72696
First Author: Liévens JC
Year: 2001
Journal: Neurobiol Dis
Title: Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
Volume: 8
Issue: 5
Pages: 807-21
•
•
•
•
•
Publication
28384474 | J:256089
First Author: Gasset-Rosa F
Year: 2017
Journal: Neuron
Title: Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport.
Volume: 94
Issue: 1
Pages: 48-57.e4
•
•
•
•
•
Publication
24906892 | J:218075
First Author: Marangoni M
Year: 2014
Journal: Neurobiol Aging
Title: Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington's disease.
Volume: 35
Issue: 10
Pages: 2382-93
•
•
•
•
•
Publication
10078572 | J:53776
First Author: Hurlbert MS
Year: 1999
Journal: Diabetes
Title: Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.
Volume: 48
Issue: 3
Pages: 649-51
•
•
•
•
•
Publication
10632104 | J:60060
First Author: Tabrizi SJ
Year: 2000
Journal: Ann Neurol
Title: Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.
Volume: 47
Issue: 1
Pages: 80-6
•
•
•
•
•
Publication
10533044 | J:76018
First Author: Levine MS
Year: 1999
Journal: J Neurosci Res
Title: Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease.
Volume: 58
Issue: 4
Pages: 515-32
•
•
•
•
•
Publication
33370315 | J:299485
First Author: Heikkinen T
Year: 2020
Journal: PLoS One
Title: Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease.
Volume: 15
Issue: 12
Pages: e0243052
•
•
•
•
•
Publication
34239412 | J:321258
 
First Author: Schindler F
Year: 2021
Journal: Front Neurosci
Title: Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington's Disease Knock-in Mice.
Volume: 15
Pages: 682172
•
•
•
•
•
Publication
18504298 | J:137025
First Author: Wang CE
Year: 2008
Journal: J Cell Biol
Title: Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin.
Volume: 181
Issue: 5
Pages: 803-16
•
•
•
•
•
Publication
18768691 | J:141171
First Author: Walker AG
Year: 2008
Journal: J Neurosci
Title: Altered information processing in the prefrontal cortex of Huntington's disease mouse models.
Volume: 28
Issue: 36
Pages: 8973-82
•
•
•
•
•
Publication
27381424 | J:236790
First Author: Dufour BD
Year: 2016
Journal: Exp Neurol
Title: Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.
Volume: 283
Issue: Pt A
Pages: 308-17
•
•
•
•
•
Publication
21505144 | J:182068
First Author: She P
Year: 2011
Journal: Am J Physiol Endocrinol Metab
Title: Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease.
Volume: 301
Issue: 1
Pages: E49-61
•
•
•
•
•
Publication
11880489 | J:75156
First Author: Ferrante RJ
Year: 2002
Journal: J Neurosci
Title: Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.
Volume: 22
Issue: 5
Pages: 1592-9
•
•
•
•
•
Publication
28993428 | J:263524
First Author: Alpaugh M
Year: 2017
Journal: EMBO Mol Med
Title: Disease-modifying effects of ganglioside GM1 in Huntington's disease models.
Volume: 9
Issue: 11
Pages: 1537-1557
•
•
•
•
•
Publication
30061661 | J:268385
First Author: Pido-Lopez J
Year: 2018
Journal: Sci Rep
Title: In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington's disease.
Volume: 8
Issue: 1
Pages: 11447
•
•
•
•
•
Publication
16446101 | J:108616
First Author: Gomez GT
Year: 2006
Journal: Mol Cell Neurosci
Title: Brain-specific factors in combination with mutant huntingtin induce gene-specific transcriptional dysregulation.
Volume: 31
Issue: 4
Pages: 661-75
•
•
•
•
•
Publication
11520890 | J:71210
First Author: Hansson O
Year: 2001
Journal: J Neurochem
Title: Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Volume: 78
Issue: 4
Pages: 694-703
•
•
•
•
•
Publication
10739639 | J:61687
First Author: Menalled L
Year: 2000
Journal: Exp Neurol
Title: Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease.
Volume: 162
Issue: 2
Pages: 328-42
•
•
•
•
•
Publication
12223581 | J:79137
First Author: Menalled LB
Year: 2002
Journal: J Neurosci
Title: Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice.
Volume: 22
Issue: 18
Pages: 8266-76
•
•
•
•
•
Publication
17335925 | J:122514
First Author: Sawada H
Year: 2007
Journal: Neurosci Res
Title: Characterization of neuron-specific huntingtin aggregates in human huntingtin knock-in mice.
Volume: 57
Issue: 4
Pages: 559-73
•
•
•
•
•
Publication
10448198 | J:56438
First Author: Manley K
Year: 1999
Journal: Brain Res
Title: Instability of the CAG repeat in immortalized fibroblast cell cultures from Huntington's disease transgenic mice.
Volume: 835
Issue: 1
Pages: 74-9
•
•
•
•
•
Publication
30182387 | J:267306
First Author: MartĂ­nez-RamĂ­rez C
Year: 2018
Journal: J Neurochem
Title: Altered excitability and exocytosis in chromaffin cells from the R6/1 mouse model of Huntington's disease is linked to over-expression of mutated huntingtin.
Volume: 147
Issue: 4
Pages: 454-476
•
•
•
•
•
Publication
11906693 | J:75438
First Author: Zeron MM
Year: 2002
Journal: Neuron
Title: Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
Volume: 33
Issue: 6
Pages: 849-60
•
•
•
•
•
Publication
9949199 | J:53797
First Author: Schilling G
Year: 1999
Journal: Hum Mol Genet
Title: Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
Volume: 8
Issue: 3
Pages: 397-407
•
•
•
•
•
Publication
11447996 | J:70215
First Author: Andreassen OA
Year: 2001
Journal: Neurobiol Dis
Title: Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease.
Volume: 8
Issue: 3
Pages: 479-91
•
•
•
•
•
Publication
21832090 | J:176722
First Author: Mandal M
Year: 2011
Journal: J Biol Chem
Title: Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin.
Volume: 286
Issue: 39
Pages: 33719-28
•
•
•
•
•
Publication
22822065 | J:190405
First Author: Martin B
Year: 2012
Journal: J Biol Chem
Title: Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.
Volume: 287
Issue: 38
Pages: 31766-82
•
•
•
•
•
Publication
28823953 | J:268583
 
First Author: Corey-Bloom J
Year: 2017
Journal: Brain Res
Title: Beneficial effects of glatiramer acetate in Huntington's disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms.
Volume: 1673
Pages: 102-110
•
•
•
•
•
Publication
36967065 | J:334909
 
First Author: Rieux M
Year: 2023
Journal: Neurobiol Dis
Title: Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis model.
Volume: 180
Pages: 106091
•
•
•
•
•
Publication
27989734 | J:260986
 
First Author: Vagner T
Year: 2016
Journal: Mol Cell Neurosci
Title: Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice.
Volume: 77
Pages: 76-86
•
•
•
•
•
Publication
38029540 | J:355292
 
First Author: Wu C
Year: 2024
Journal: Biochem Biophys Res Commun
Title: Altered anterograde axonal transport of mitochondria in cultured striatal neurons of a knock-in mouse model of Huntington's disease.
Volume: 691
Pages: 149246
•
•
•
•
•
Publication
34429377 | J:353008
First Author: Woodard CL
Year: 2021
Journal: J Neurosci
Title: Impaired Refinement of Kinematic Variability in Huntington Disease Mice on an Automated Home Cage Forelimb Motor Task.
Volume: 41
Issue: 41
Pages: 8589-8602
•
•
•
•
•
Publication
18805465 | J:142854
First Author: Hickey MA
Year: 2008
Journal: Neuroscience
Title: Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.
Volume: 157
Issue: 1
Pages: 280-95
•
•
•
•
•
Publication
29259100 | J:259013
 
First Author: Abd-Elrahman KS
Year: 2017
Journal: Sci Signal
Title: mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington's disease.
Volume: 10
Issue: 510
•
•
•
•
•
Publication
33113354 | J:298610
First Author: Friedman A
Year: 2020
Journal: Cell
Title: Striosomes Mediate Value-Based Learning Vulnerable in Age and a Huntington's Disease Model.
Volume: 183
Issue: 4
Pages: 918-934.e49
•
•
•
•
•
Publication
33556538 | J:307172
 
First Author: Ravalia AS
Year: 2021
Journal: Neurobiol Dis
Title: Super-resolution imaging reveals extrastriatal synaptic dysfunction in presymptomatic Huntington disease mice.
Volume: 152
Pages: 105293
•
•
•
•
•
Publication
26210937 | J:227288
 
First Author: Fowler SC
Year: 2015
Journal: Behav Brain Res
Title: Use of a force-sensing automated open field apparatus in a longitudinal study of multiple behavioral deficits in CAG140 Huntington's disease model mice.
Volume: 294
Pages: 7-16
•
•
•
•
•
Publication
27219491 | J:237391
First Author: Deng YP
Year: 2016
Journal: J Comp Neurol
Title: Cholinergic interneurons in the Q140 knockin mouse model of Huntington's disease: Reductions in dendritic branching and thalamostriatal input.
Volume: 524
Issue: 17
Pages: 3518-3529
•
•
•
•
•
Publication
30333735 | J:276314
 
First Author: Piiponniemi TO
Year: 2018
Journal: Front Behav Neurosci
Title: Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning Task.
Volume: 12
Pages: 226
•
•
•
•
•
Publication
19566678 | J:152247
First Author: Kegel KB
Year: 2009
Journal: J Neurochem
Title: Polyglutamine expansion in huntingtin alters its interaction with phospholipids.
Volume: 110
Issue: 5
Pages: 1585-97
•
•
•
•
•
Publication
32984817 | J:296442
First Author: Zhang C
Year: 2020
Journal: Cereb Cortex Commun
Title: Abnormal Brain Development in Huntington' Disease Is Recapitulated in the zQ175 Knock-In Mouse Model.
Volume: 1
Issue: 1
Pages: tgaa044
•
•
•
•
•
Publication
32869871 | J:316270
First Author: Deng Y
Year: 2021
Journal: J Comp Neurol
Title: Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.
Volume: 529
Issue: 7
Pages: 1327-1371
•
•
•
•
•
Publication
23936129 | J:204943
First Author: Loh DH
Year: 2013
Journal: PLoS One
Title: The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep.
Volume: 8
Issue: 7
Pages: e69993
•
•
•
•
•
Publication
30118496 | J:264551
First Author: Goodliffe JW
Year: 2018
Journal: PLoS One
Title: Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.
Volume: 13
Issue: 8
Pages: e0200626
•
•
•
•
•
Publication
23284626 | J:195639
First Author: Menalled LB
Year: 2012
Journal: PLoS One
Title: Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Volume: 7
Issue: 12
Pages: e49838
•
•
•
•
•
Publication
28893927 | J:249121
First Author: Hong Y
Year: 2017
Journal: J Neurosci
Title: Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
Volume: 37
Issue: 39
Pages: 9550-9563
•
•
•
•
•
Publication
37446179 | J:337897
 
First Author: Pinchaud K
Year: 2023
Journal: Int J Mol Sci
Title: Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum.
Volume: 24
Issue: 13
•
•
•
•
•
Publication
37996924 | J:342954
First Author: Steinberg N
Year: 2023
Journal: J Neuroinflammation
Title: NaĂ¯ve Huntington's disease microglia mount a normal response to inflammatory stimuli but display a partially impaired development of innate immune tolerance that can be counteracted by ganglioside GM1.
Volume: 20
Issue: 1
Pages: 276
•
•
•
•
•
Publication
22044764 | J:191395
First Author: Hickey MA
Year: 2012
Journal: Mol Cell Neurosci
Title: Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.
Volume: 49
Issue: 2
Pages: 149-57
•
•
•
•
•
Publication
26546830 | J:229392
 
First Author: Rothe T
Year: 2015
Journal: Neuroscience
Title: Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice.
Volume: 311
Pages: 519-38
•
•
•
•
•
Publication
26793080 | J:244063
 
First Author: Curtin PC
Year: 2015
Journal: Front Behav Neurosci
Title: Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HD.
Volume: 9
Pages: 361
•
•
•
•
•
Publication
30517854 | J:270768
First Author: Yang S
Year: 2018
Journal: Cell Rep
Title: Shortening the Half-Life of Cas9 Maintains Its Gene Editing Ability and Reduces Neuronal Toxicity.
Volume: 25
Issue: 10
Pages: 2653-2659.e3
•
•
•
•
•
Publication
23969239 | J:201754
 
First Author: Deng YP
Year: 2013
Journal: Neurobiol Dis
Title: Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.
Volume: 60
Pages: 89-107
•
•
•
•
•
Publication
32897880 | J:308961
 
First Author: Dridi H
Year: 2020
Journal: JCI Insight
Title: Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease.
Volume: 5
Issue: 19
•
•
•
•
•
Publication
21192926 | J:170725
First Author: Rising AC
Year: 2011
Journal: Exp Neurol
Title: Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Volume: 228
Issue: 2
Pages: 173-82
•
•
•
•
•
Publication
30819797 | J:275509
First Author: Dvorzhak A
Year: 2019
Journal: J Neurosci
Title: Single Synapse Indicators of Impaired Glutamate Clearance Derived from Fast iGlu u Imaging of Cortical Afferents in the Striatum of Normal and Huntington (Q175) Mice.
Volume: 39
Issue: 20
Pages: 3970-3982
•
•
•
•
•
Publication
29302618 | J:263593
 
First Author: Wang HB
Year: 2018
Journal: eNeuro
Title: Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington's Disease.
Volume: 5
Issue: 1
•
•
•
•
•
Publication
30472747 | J:353392
First Author: Holley SM
Year: 2019
Journal: Eur J Neurosci
Title: Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease.
Volume: 49
Issue: 1
Pages: 79-93
•
•
•
•
•
Publication
27147650 | J:231733
First Author: Dvorzhak A
Year: 2016
Journal: J Neurosci
Title: Functional Indicators of Glutamate Transport in Single Striatal Astrocytes and the Influence of Kir4.1 in Normal and Huntington Mice.
Volume: 36
Issue: 18
Pages: 4959-75
•
•
•
•
•
Publication
22327034 | J:182282
First Author: Murphy-Nakhnikian A
Year: 2012
Journal: Neurosci Lett
Title: Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington's disease mice.
Volume: 512
Issue: 1
Pages: 1-5
•
•
•
•
•
Publication
28930690 | J:254932
First Author: Merienne N
Year: 2017
Journal: Cell Rep
Title: The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.
Volume: 20
Issue: 12
Pages: 2980-2991
•
•
•
•
•
Publication
31379510 | J:284447
 
First Author: Quirion JG
Year: 2019
Journal: Front Cell Neurosci
Title: The Onset and Progression of Hippocampal Synaptic Plasticity Deficits in the Q175FDN Mouse Model of Huntington Disease.
Volume: 13
Pages: 326
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom